Aldeyra Therapeutics (ALDX) Tax Rate (2019 - 2020)
Aldeyra Therapeutics (ALDX) posted Tax Rate of 4.07% for Q4 2020, up 5472.75% on a QoQ basis from 0.08% in Q4 2019, and up 415.0% year-over-year from 0.79% in Q1 2020.
Aldeyra Therapeutics (ALDX) Tax Rate (2019 - 2020) Analysis & Trends
Aldeyra Therapeutics' Tax Rate history runs 2 years deep, the most recent figure standing at 4.07% for Q4 2020.
- Quarterly Tax Rate rose 415.0% year-over-year to 4.07% in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 1.26% (down 83.0% YoY) and the FY2020 annual result came in at 1.26%, down 83.0% from the prior year.
- Tax Rate was 4.07% for Q4 2020 at Aldeyra Therapeutics, up from 0.08% in the prior quarter.
- Across five years, Tax Rate topped out at 7.68% in Q1 2019 and bottomed at 0.08% in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | 5.61% |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 12.29% |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 33.09% |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 7.07% |
| 10 | Aldeyra Therapeutics | 94.70 Mn | 94.70 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 4.07% |
| Dec 31, 2020 | 4.07% |
| Dec 31, 2020 | 4.07% |
| Dec 31, 2019 | -0.08% |
| Dec 31, 2019 | -0.08% |
| Dec 31, 2019 | -0.08% |
| Jun 30, 2019 | 0.07% |
| Jun 30, 2019 | 0.07% |
| Jun 30, 2019 | 0.07% |
| Mar 31, 2019 | 7.68% |
| Mar 31, 2019 | 7.68% |
| Mar 31, 2019 | 7.68% |